OOIR: Observatory of International Research

Papers

(The median citation count of Critical Reviews in Microbiology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Male-specific bacteriophages and their potential on combating the spreading of T4SS-bearing antimicrobial resistance plasmids	122
Dynamics of antibiotic resistance genes in plasmids and bacteriophages	88
TREM-2: friend or foe in infectious diseases?	68
Neuroinflammation-mediated relationship between oral microbiome and neurodegenerative diseases	63
Salmonella in eggs and egg-laying chickens: pathways to effective control	59
Current and emerging therapies for fungal biofilms and systemic infections	50
Host and bacterial lipid metabolism during tuberculosis infections: possibilities to synergise host- and bacteria-directed therapies	49
Paving the way forward: Escherichia coli bacteriophages in a One Health approach	43
Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases	43
Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens	42
Outer membrane proteins and vesicles as promising vaccine candidates against Vibrio spp. infections	40
Antibiotic heteroresistance: an important factor in the failure of Helicobacter Pylori eradication	40
Elucidating the multifaceted antibacterial mechanisms of luteolin: insights, challenges, and prospects for clinical translation	36
Targeting bioinformatics tools to study the dissemination and spread of antibiotic resistant genes in the environment and clinical settings	33
Exploring halophilic environments as a source of new antibiotics	32
Under the lens: using Raman spectroscopy as a unique system in biofilm analyses	30
Interplay between Clostridioides difficile infection, host immunity, and metabolism: a comprehensive review	29
LysR-type transcriptional regulators: state of the art	29
Vibrio cholerae virulence and its suppression through the quorum-sensing system	28
The crosstalk between gut microbiota and microbiota-derived metabolites in hepatocellular carcinoma	27
Helicobacter pylori ’s secret resilience: coccoid forms, yeast havens, and outer membrane vesicle release for survival and spread	26
Advances in the applications of Bacteriophages and phage products against food-contaminating bacteria	25
Helicobacter pylori eradication: developing antibiotic-independent antimicrobial moieties	25
Polyamine as a microenvironment factor in resistance to antibiotics	23
The diffusible signaling factor family in microbial signaling: a current perspective	22

The role of single and mixed biofilms in Clostridioides difficile infection and strategies for prevention and inhibition	22
Bacterial vaginosis: advancing insights into microbial dysbiosis	22
Recent advances in omics-driven research of photosynthetic microorganisms in green biotechnology	21
Probiotics for pancreatic β-cell function: from possible mechanism of action to assessment of effectiveness	21
Endophytic fungi-bioinspired nanoparticles potential to control infectious disease	21
Emergence of persister cells in Staphylococcus aureus : calculated or fortuitous move?	20
Microbial persisters and host: recent advances and future perspectives	19
Molecular mechanisms of Klebsiella pneumoniae pathogenicity: from virulence factors to emerging therapeutic strategies	19
Antibiotic resistance in Pseudomonas aeruginosa : mechanisms and emerging treatment	19
Biotherapeutic potential of gut microbiota-derived indole-3-acetic acid	18
Emerging strategies to target virulence in Pseudomonas aeruginosa respiratory infections	18
Ocular surface microbiota dysbiosis contributes to the high prevalence of dry eye disease in diabetic patients	17
Microbial biosynthesis of nucleos(t)ide analogs: applications, and engineering optimization	17
Ureaplasma infections: update on epidemiology, antimicrobial resistance, and pathogenesis	17
The resilient microbiome: how baseline gut microbial composition influences response to cancer treatment	17
Quorum sensing in biofilms: a key mechanism to target in ecotoxicological studies	16
Bacterial kinase in ESKAPE pathogen: regulators of virulence and novel therapeutic targets	16
Revisiting the antimicrobial potential of metalloporphyrins: from food to pharma	16
Current types of staphylococcal cassette chromosome mec (SCC mec ) in clinically relevant coagulase-negative staphylococcal (CoNS) species	16
Community dynamics of subgingival microbiome in periodontitis and targets for microbiome modulation therapy	15
Mechanisms underlying the effects, and clinical applications, of oral microbiota in lung cancer: current challenges and prospects	15
The crosstalk between SUMOylation and immune system in host-pathogen interactions	15
Porphyromonas gingivalis and the pathogenesis of Alzheimer’s disease	15
Aspergilli series Versicolores: importance of species identification in the clinical setting	15
Review on computer-assisted biosynthetic capacities elucidation to assess metabolic interactions and communication within microbial communities	15
Anti-virulence peptides: a compromising strategy to treat Staphylococcus aureus chronic wound infection	14
Insights into the molecular basis of c-di-GMP signalling in Pseudomonas aeruginosa	14
The potential for bacteriophages and prophage elements in fighting and preventing the gonorrhea	14
Genetic basis of antibiotic resistance in bovine mastitis and its possible implications for human and ecological health	13
Roles of alcohol dehydrogenase 1 in the biological activities of Candida albicans	13
Natural and synthetic molecules with potential to enhance biofilm formation and virulence properties in Pseudomonas aeruginosa	13
Antibiotic resistance genes in Escherichia coli – literature review	13
Phage-inspired strategies to combat antibacterial resistance	13
Current and novel therapies for management of Acinetobacter baumannii -associated pneumonia	12
Type IV pilin regulation: a transcriptional overview	12
Marine microbial enzymes as potential antibiofilm agents: expanding the arsenal of bioactive agents targeting biofilm-forming microorganisms	12
Virovory: control of viral pathogenesis by the protists and the way forward	11
Microparticles and nanoparticles-based approaches to improve oral treatment of Helicobacter pylori infection	11
Ex vivo challenge models for infectious diseases	11
The final gate: bacterial subversion of autophagosome-lysosome fusion as a conserved immune evasion strategy	11
The complement system as a key modulator of the oral microbiome in health and disease	11
Towards the discovery of novel molecular clocks in Prokaryotes	11
Friends and foes: impact of bacteria on genome stability	11
Multiple potential strategies for the application of nisin and derivatives	11
Mycobacterium avium biofilms: mechanism of production, composition, and its role in pathogenesis and drug resistance	11
Molecular imaging of bacterial biofilms—a systematic review	10
Thermogenesis dynamics and influenza A virus: unveiling the intriguing interplay	10
Acinetobacter baumannii subunit vaccines: recent progress and challenges	10
Rapid diagnosis and precision treatment of Helicobacter pylori infection in clinical settings	10
Peeling off the layers from microbial dark matter (MDM): recent advances, future challenges, and opportunities	10

How force drives pathogenicity: mechanoregulation of Streptococcus mutans adhesion to collagen	10
The therapeutic potential of phage-based antifungal treatment: strategies, mechanisms, and prospects	10
Microbial bioemulsifiers as tools in biofilm disruption and prevention: state-of-the-art and emerging frontiers	9
Metabolomics in influenza viral infection: insights into host–virus interactions and potential biomarkers of severe outcomes	8
Peptide-based strategies for overcoming biofilm-associated infections: a comprehensive review	8
Macrophage biology in the pathogenesis of Helicobacter pylori infection	8
Nasal microbiome dynamics: decoding the intricate nexus in the progression of respiratory and neurological diseases	8
Are anaerobic fungi crucial hidden players of microbiomes in anoxic environment?	8
A comprehensive review of Bifidobacterium spp : as a probiotic, application in the food and therapeutic, and forthcoming trends	7
Glycosylation orchestrates virulence and pathogenicity of periodontal keystone pathogens	7
Pathogenesis of leptospirosis-induced coagulopathy and hemorrhages	7
Biofilm-associated Escherichia coli infections: pathogenesis, clinical implications, and treatment strategies	7
Selective pressures for public antibiotic resistance	7
Blocking horizontal transfer of antibiotic resistance genes: an effective strategy in combating antibiotic resistance	7
Polymicrobial biofilms related to dental implant diseases: unravelling the critical role of extracellular biofilm matrix	7
Activation of host nucleic acid sensors by Mycobacterium : good for us or good for them?	7
Non-antibiotic compounds associated with humans and the environment can promote horizontal transfer of antimicrobial resistance genes	6
The battle within: how Pseudomonas aeruginosa uses host-pathogen interactions to infect the human lung	6
Evaluation of the antifungal effect of plant extracts on oral Candida spp. – a critical methodological analysis of the last decade	6
A multifarious bacterial surface display: potential platform for biotechnological applications	6
The development and application of the Environmental Relative Moldiness Index (ERMI)	6
Insight into the multifactorial effect of climate change on marine bacteria: resilience mechanisms and mitigation strategies	6
Water and mosquitoes as key components of the infective cycle of Francisella tularensis in Europe: a review	6
Food and gut originated bacteriocins involved in gut microbe-host interactions	5
Mycobacterium abscessus: insights from a bioinformatic perspective	5
Interplay between lipid metabolism, lipid droplets and RNA virus replication	5
Botanicals as promising antimicrobial agents for enhancing oral health: a comprehensive review	5
Applications of the phage display technology in molecular biology, biotechnology and medicine	5
Anti-fungal peptides: an emerging category with enthralling therapeutic prospects in the treatment of candidiasis	5
Transformation of colitis and colorectal cancer: a tale of gut microbiota	5
Probiotics: insights and new opportunities for Clostridioides difficile intervention	5
Ferroptosis, from the virus point of view: opportunities and challenges	5
Current developments and prospects of the antibiotic delivery systems	5
The role of bacteriophage in inflammatory bowel disease and its therapeutic potential	5
The implication of microbiome in lungs cancer: mechanisms and strategies of cancer growth, diagnosis and therapy	5